Загрузка...
Evolving treatment approaches for the management of metastatic castration-resistant prostate cancer – role of radium-223
Radium-223 is a first-in-class alpha particle-emitting radiopharmaceutical approved for the treatment of bone metastatic castration-resistant prostate cancer. Radium-223 is administered intravenously with no requirement for complex shielding and specifically targets areas of bone metastasis. In a ra...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4043797/ https://ncbi.nlm.nih.gov/pubmed/24920911 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S45667 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|